within Pharmacolibrary.Drugs.ATC.A;

model A09AC01
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 1,
    Cl             = 0.0,
    adminDuration  = 600,
    adminMass      = 40 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.001,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.016666666666666666,
    Tlag           = 600
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>A09AC01</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Pepsin and acid preparations are oral digestive aids that contain the enzyme pepsin, which breaks down proteins in the stomach, often combined with hydrochloric acid or acidifiers to enhance gastric acidity. Historically, these preparations have been used to treat conditions of low stomach acid (hypochlorhydria) and to aid protein digestion but are rarely used or recommended in modern clinical practice due to lack of proven clinical benefit and the availability of more effective therapies.</p><h4>Pharmacokinetics</h4><p>No published pharmacokinetic studies found in humans for pepsin and acid preparations; as pepsin is a protein enzyme intended to act locally in the stomach and is inactivated/digested by the gastrointestinal tract, systemic absorption and classical pharmacokinetic parameters are not applicable.</p><h4>References</h4><ol><li><p>Baranauskaite, J, et al., &amp; Bernatoniene, J (2018). Liposomal Incorporation to Improve Dissolution and Stability of Rosmarinic Acid and Carvacrol Extracted from Oregano (. <i>BioMed research international</i> 2018 6147315–None. DOI:<a href=\"https://doi.org/10.1155/2018/6147315\">10.1155/2018/6147315</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/30140697/\">https://pubmed.ncbi.nlm.nih.gov/30140697</a></p></li><li><p>Maharaj, AR, et al., &amp; Fotaki, N (2016). Assessment of Age-Related Changes in Pediatric Gastrointestinal Solubility. <i>Pharmaceutical research</i> 33(1) 52–71. DOI:<a href=\"https://doi.org/10.1007/s11095-015-1762-7\">10.1007/s11095-015-1762-7</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/26220249/\">https://pubmed.ncbi.nlm.nih.gov/26220249</a></p></li><li><p>Kim, CK, et al., &amp; Gao, ZG (2001). Preparation and evaluation of biphenyl dimethyl dicarboxylate microemulsions for oral delivery. <i>Journal of controlled release : official journal of the Controlled Release Society</i> 70(1-2) 149–155. DOI:<a href=\"https://doi.org/10.1016/s0168-3659(00)00343-6\">10.1016/s0168-3659(00)00343-6</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/11166415/\">https://pubmed.ncbi.nlm.nih.gov/11166415</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end A09AC01;
